CAS: 334827-98-4
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Gisadenafil besylate salt REF: 7W-GL9139CAS: 334827-98-4 | - - - | To inquire | Tue 07 Jan 25 | |
Gisadenafil Besylate REF: 4Z-G-181002CAS: 334827-98-4 | - - - | To inquire | Mon 13 Jan 25 | |
Gisadenafil besylate REF: TM-T11400CAS: 334827-98-4 | - - - | To inquire | Mon 10 Mar 25 | |
Gisadenafil besylate salt REF: 3D-JNA82798CAS: 334827-98-4 | Min. 95% | - - - | Discontinued product |
Ref: 4Z-G-181002
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Monday 13 Jan 2025
Gisadenafil besylate
CAS:334827-98-4
Gisadenafil besylate, a PDE5 inhibitor, is orally active, prevents cGMP degradation, with an IC50 of …
Formula:
C29H39N7O8S2
Color and Shape:
Solid
Molecular weight:
677.79
Ref: TM-T11400
25mg | 634.00 € | ||
50mg | 832.00 € | ||
100mg | 1,255.00 € |
Estimated delivery in United States, on Monday 10 Mar 2025
Gisadenafil besylate salt
CAS:334827-98-4
Gisadenafil is an oral, selective alpha-1A adrenergic receptor agonist that is used for the treatment …
Formula:
C23H33N7O5S·C6H6O3S
Purity:
Min. 95%
Molecular weight:
677.79 g/mol
Ref: 3D-JNA82798
5mg | Discontinued | Request information | |
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information |